Abstract
This article comments on the study by Gazdaru et al., who report a case of chronic myeloid leukemia resistant to tyrosine kinase inhibitors (TKIs). Treatment by TKI was replaced by interferon‐α (INF‐α), and the patient underwent hematopoietic stem cell transplantation, resulting in successful ovarian stimulation for fertility preservation.